Long-Term Study of Postmenopausal Women Does Not Support Many Preventive Therapies
By Lori Solomon HealthDay Reporter
THURSDAY, May 2, 2024 -- The longitudinal Women's Health Initiative trials do not support hormone therapy for cardiovascular disease prevention, calcium and vitamin D supplementation for universal fracture prevention, or a low-fat diet for cancer prevention, according to a review published online May 1 in the Journal of the American Medical Association.
JoAnn E. Manson, M.D., Dr.P.H., from Brigham and Women's Hospital in Boston, and colleagues examined the effects of menopausal hormone therapy, calcium plus vitamin D supplementation, and a low-fat dietary pattern on health among 68,132 postmenopausal U.S. women (aged 50 to 79 years at baseline from 1993 to 1998), who were followed for 20 years as part of the Women's Health Initiative.
The researchers found the results do not support hormone therapy with oral conjugated equine estrogens plus medroxyprogesterone acetate for postmenopausal women or conjugated equine estrogens alone for those with prior hysterectomy to prevent cardiovascular disease, dementia, or other chronic diseases, although hormone therapy is effective for treating moderate to severe vasomotor and other menopausal symptoms before age 60 years. Furthermore, the trial results do not support universally recommending calcium plus vitamin D supplementation for fracture prevention, although supplementation is appropriate for women who do not meet national guidelines for recommended intakes of these nutrients through diet. While a low-fat dietary pattern (with increased fruit, vegetable, and grain consumption) does not prevent breast or colorectal cancer, it was associated with lower rates of breast cancer mortality during long-term follow-up.
"Individualized patient care and shared decision-making should be implemented, taking into account patient preferences, severity of symptoms, and cardiometabolic and general health status," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Overall Burden of CVD Remained High in United Kingdom in 2000 to 2019
THURSDAY, June 27, 2024 -- The overall burden of cardiovascular disease (CVD) remained high during 2000 to 2019 in the United Kingdom, according to a study published online June...
hs-cTnT Linked to MACE, Mortality in Rheumatoid Arthritis
THURSDAY, June 27, 2024 -- For patients with rheumatoid arthritis (RA), a detectable level of high-sensitivity cardiac troponin T (hs-cTnT) is associated with increased risk of...
Childhood Risk Factors Directly Tied to Adult Cardiovascular Disease
MONDAY, June 24, 2024 -- Childhood risk factors are associated both directly and indirectly to adult cardiovascular disease (CVD), according to a study published online June 24...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.